GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2276 - 2300** of **4050** in total

« First

‹ Prev

…

88

89

90

91

92

93

94

95

96

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgM	Patient 3	11	mild	G49916XD	1022
IgM	Patient 3	4	mild	G49916XD	1024
IgA	Patient 4	12	mild	G49916XD	555
IgG	Patient 4	12	mild	G49916XD	107
IgM	Patient 4	12	mild	G49916XD	828
IgA	Patient 1	10	moderate	G51175PR	304
IgA	Patient 1	22	moderate	G51175PR	334
IgA	Patient 1	6	moderate	G51175PR	311
IgG	Patient 1	10	moderate	G51175PR	26
IgG	Patient 1	22	moderate	G51175PR	30
IgM	Patient 1	10	moderate	G51175PR	49
IgM	Patient 1	22	moderate	G51175PR	96
IgA	Patient 2	15	mild	G51175PR	533
IgA	Patient 2	24	mild	G51175PR	665
IgG	Patient 2	15	mild	G51175PR	106
IgG	Patient 2	24	mild	G51175PR	120
IgM	Patient 2	15	mild	G51175PR	561
IgM	Patient 2	24	mild	G51175PR	763
IgG	Patient 1	6	moderate	G51175PR	28
IgM	Patient 1	6	moderate	G51175PR	49
IgA	Patient 2	3	mild	G51175PR	465
IgG	Patient 2	3	mild	G51175PR	84
IgM	Patient 2	3	mild	G51175PR	213
IgA	Patient 3	-180	mild	G51175PR	1389
IgA	Patient 3	11	mild	G51175PR	1499